I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immunogenicity and safety of single booster dose of KD-414 ..:
Junko Terada-Hirashima
;
Yuki Takamatsu
;
Yosuke Shimizu
...
http://dx.doi.org/10.1080/21645515.2023.2193074. , 2023
Link:
https://doi.org/10.1080/21645515.2023.2193074
RT Journal T1
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:9e1eb62a8e1847b9bf4013d1581744ff&Exemplar=1&LAN=DE A1 Junko Terada-Hirashima A1 Yuki Takamatsu A1 Yosuke Shimizu A1 Yukari Uemura A1 Junko S. Takeuchi A1 Noriko Tomita A1 Kouki Matsuda A1 Kenji Maeda A1 Shohei Yamamoto A1 Ami Fukunaga A1 Norio Ohmagari A1 Ayako Mikami A1 Kengo Sonoda A1 Mugen Ujiie A1 Hiroaki Mitsuya A1 Wataru Sugiura PB Taylor & Francis Group YR 2023 K1 covid-19 K1 sars-cov-2 K1 covid-19 vaccine K1 inactivated vaccine K1 side effects K1 adverse events K1 vaccine safety K1 neutralizing antibody K1 kd-414 K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/21645515.2023.2193074 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2023.2193074 DO https://doi.org/10.1080/21645515.2023.2193074 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)